ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

AP-HP at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

AP-HP brings 9 presentations to ACR Convergence 2026 in Orlando. Its program centres on vasculitis, including obinutuzumab and rituximab experience, urticarial and necrotizing forms, and Behçet disease. It also covers axial spondyloarthritis classification and genetics, lupus with anti-interferon autoantibodies, and systemic sclerosis treatment.

OrganizationACR Convergence 2026 Attendance
AP-HP
Paris, France
Hospitals and health systems
The public hospital system serving Paris and the Île-de-France region.
Poster
Sun Nov 8
10:30am–12:30pm
Talk
Wed Nov 11
9:00am–9:30am
Part of Behçet Syndrome: Updates in Pathogenesis, Diagnosis, and Management
Bridging Bench and Bedside: Pathogenic Insights in Behçet Disease
W415A
Vasculitis

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AP-HP

Tell us what you sell and we’ll find the people at AP-HP most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction